Another study has reported that LRRK2 localizes to enlarged lysosomes or vacuoles in brains of Lewy body disease patients (Higashi et al., 2009), raising the possibility that CASM-mediated lysosomal targeting of LRRK2 is activated in pathological conditions. Here, LRRK2 is linked to Lewy body dementia.